Cargando…
Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies
Cancer biomarker discovery is critically dependent on the integrity of biofluid and tissue samples acquired from study participants. Multi-omic profiling of candidate protein, lipid, and metabolite biomarkers is confounded by timing and fasting status of sample collection, participant demographics a...
Autores principales: | Searfoss, Richard, Shah, Punit, Ofori-Mensa, Kennedy, Bussberg, Valerie, Tolstikov, Vladimir, Greenwood, Bennett, Li, Hongyan, Richardson, Kris, Miller, Gregory M., DeCicco, Corinne, Granger, Elder, Rodrigues, Leonardo O., Grund, Eric M., Moser, A. James, Sarangarajan, Rangaprasad, Narain, Niven R., Kiebish, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786830/ https://www.ncbi.nlm.nih.gov/pubmed/35075163 http://dx.doi.org/10.1038/s41598-022-05152-8 |
Ejemplares similares
-
Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics
por: Tolstikov, Vladimir, et al.
Publicado: (2020) -
Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
por: Sarangarajan, Rangaprasad, et al.
Publicado: (2020) -
OMRT-13. Delivery of Ubidecarenone (BPM 31510) to mitochondria effectuates metabolic reprogramming and redox activated apoptosis in Glioblastoma
por: Sarangarajan, Rangaprasad, et al.
Publicado: (2021) -
Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
por: Chi, Jen‐Tsan, et al.
Publicado: (2020) -
Integrated Metabolomics Assessment of Human Dried Blood Spots and Urine Strips
por: Drolet, Jeremy, et al.
Publicado: (2017)